Week50, 2023
1. Influenza activity is elevated and continues to increase nationally, with 12.8% of respiratory specimens testing positive for influenza this week.
2. Of the 1,050 positive specimens from public health labs, 81.9% were Influenza A and 18.1% Influenza B; Influenza A(H1N1) was the predominant subtype, representing 78.2% of subtyped Influenza A viruses.
3. Outpatient visits for respiratory illness accounted for 5.1% of all visits, remaining above the national baseline for the seventh consecutive week, with ILI activity increasing across all regions and age groups.
4. A cumulative influenza hospitalization rate of 11.3 per 100,000 was reported, with adults aged 65+ having the highest rate (28.1 per 100,000).
5. Weekly hospitalizations rose to 9,825, increasing nationally compared to last week.
6. Deaths attributed to influenza remain low at 0.3% of all deaths this week, with no new pediatric deaths reported (14 total this season).
7. Thus far, 5.3 million illnesses, 54,000 hospitalizations, and 3,200 deaths have occurred during the 2023-2024 flu season.
8. No novel influenza viruses (e.g., SARS-CoV-2) were reported circulating this week, but co-circulation of multiple respiratory viruses, including RSV, is ongoing.
9. CDC recommends immediate vaccination for those unvaccinated, as flu vaccines for the season are still available.
10. Antiviral susceptibility monitoring indicates most circulating influenza viruses remain sensitive to prescribed treatments, with minimal resistance noted.